“…It is conceivable that CSN5 plays a significant role in cancer since many key tumor suppressors and oncogene products are regulated by ubiquitination-and proteasome-mediated protein degradation, such as MYC, p27, TGFb1, MIF, c-Jun, E2F1, p53, Cullin, Smad4 and HIF1alpha. 3,4,[12][13][14] CSN5 has an emerging role in cancer. Actually, CSN5 was found to be overexpressed in a variety of human cancers, such as ovarian cancer, 15 breast carcinoma, 16 pancreatic cancer, 17 hepatocellular carcinoma, 18 nasopharyngeal carcinoma, 19 colorectal cancer, 20 neuroblastoma 21 and lung adenocarcinoma.…”